<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19136" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Central Retinal Artery Occlusion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Shalin S.</given-names>
          </name>
          <aff>S N Eye Hospital, Vadodara</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Waymack</surname>
            <given-names>James R.</given-names>
          </name>
          <aff>Southern Illinois University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shalin Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>James Waymack declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19136.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Central retinal arterial occlusion is an ophthalmic emergency characterized by the sudden blockage of the central retinal artery, the primary blood vessel supplying the retina. This occlusion leads to rapid and severe vision loss in the affected eye. The most common cause of central retinal arterial occlusion is an embolus&#x000a0;that obstructs the artery from the carotid artery or the heart. The sudden interruption of blood flow to the retina results in ischemia, causing damage to the retinal cells. Patients with central retinal arterial occlusion typically experience sudden, painless vision loss, necessitating immediate medical attention to address the underlying cause and attempt to restore blood flow. Unfortunately, the prognosis for visual recovery in central retinal arterial occlusion is limited, making early diagnosis and intervention critical in managing this serious eye condition.&#x000a0;</p>
        <p>This activity describes&#x000a0;the etiology, epidemiology, clinical presentation, evaluation, and management of central retinal arterial occlusion,&#x000a0;providing clinicians&#x000a0;with the knowledge and tools&#x000a0;to improve patient care. Participating clinicians within emergency medicine, ophthalmology, and related disciplines are equipped to intervene when treating patients with central retinal arterial occlusion.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of central retinal arterial occlusion based on patient history and physical examination.</p></list-item><list-item><p>Determine the prognosis of patients with central retinal arterial occlusion based on monitoring of vision.</p></list-item><list-item><p>Develop comprehensive care plans for&#x000a0;managing&#x000a0;central arterial retinal occlusion by assessing patient comorbidities and risk factors.</p></list-item><list-item><p>Collaborate with interdisciplinary healthcare teams, including ophthalmologists, cardiologists, and primary care physicians, to ensure comprehensive care for patients with central retinal artery occlusion.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19136&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19136">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19136.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Central retinal artery occlusion (CRAO) is an ophthalmic emergency that can lead to sudden and severe vision loss.<xref ref-type="bibr" rid="article-19136.r1">[1]</xref>&#x000a0;CRAO has been defined as interruption of blood flow through the central retinal artery by thromboembolism or vasospasm with or without retinal ischemia.&#x000a0;An embolus from the carotid artery, aortic arch, or heart often causes the condition.&#x000a0;Giant cell arteritis is another rare but serious cause of CRAO.<xref ref-type="bibr" rid="article-19136.r2">[2]</xref>&#x000a0;The condition is similar to a cerebral ischemic event and is associated with an increased risk of subsequent cerebral stroke and ischemic heart disease.<xref ref-type="bibr" rid="article-19136.r3">[3]</xref><xref ref-type="bibr" rid="article-19136.r4">[4]</xref><xref ref-type="bibr" rid="article-19136.r5">[5]</xref><xref ref-type="bibr" rid="article-19136.r6">[6]</xref>&#x000a0;Unfortunately, no established therapies exist to improve visual outcomes in CRAO.<xref ref-type="bibr" rid="article-19136.r7">[7]</xref> Therefore, management should focus on preventing further vascular events, such as cerebral ischemia and cardiovascular death.<xref ref-type="bibr" rid="article-19136.r8">[8]</xref>&#x000a0;Although visual prognosis is&#x000a0;typically poor, early diagnosis and&#x000a0;treatment of CRAO can&#x000a0;restore&#x000a0;visual acuity in&#x000a0;some patients.<xref ref-type="bibr" rid="article-19136.r9">[9]</xref><xref ref-type="bibr" rid="article-19136.r10">[10]</xref></p>
      </sec>
      <sec id="article-19136.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>CRAO is classified into nonarteritic CRAO and arteritic CRAO according to the basic pathophysiology.<xref ref-type="bibr" rid="article-19136.r11">[11]</xref>&#x000a0;Nonarteritic CRAO comprises more than 90% of cases.<xref ref-type="bibr" rid="article-19136.r12">[12]</xref>&#x000a0;An embolism is the most common cause of nonarteritic CRAO.<xref ref-type="bibr" rid="article-19136.r3">[3]</xref>&#x000a0;Atherosclerosis of the carotid artery may be noted on the same side in around 70% of patients with CRAO or branch retinal arterial occlusion.<xref ref-type="bibr" rid="article-19136.r13">[13]</xref><xref ref-type="bibr" rid="article-19136.r14">[14]</xref> The emboli may be composed of solid, liquid, or gaseous material and are carried from a distant source&#x000a0;through the blood flow in the arteries.<xref ref-type="bibr" rid="article-19136.r15">[15]</xref>&#x000a0;The&#x000a0;3 main types of emboli are cholesterol (Hollenhorst plaques), calcium, and platelet-fibrin.<xref ref-type="bibr" rid="article-19136.r16">[16]</xref> The most common type of retinal embolus is composed of cholesterol, accounting for around 46% to 80% of all retinal emboli.&#x000a0;Platelet-fibrin is the second most common type, accounting for 6% to 32%.&#x000a0;Calcific embolus is less common,&#x000a0;accounting for 6% to 16%.<xref ref-type="bibr" rid="article-19136.r17">[17]</xref><xref ref-type="bibr" rid="article-19136.r18">[18]</xref><xref ref-type="bibr" rid="article-19136.r19">[19]</xref><xref ref-type="bibr" rid="article-19136.r20">[20]</xref><xref ref-type="bibr" rid="article-19136.r21">[21]</xref>&#x000a0;</p>
        <p>Cholesterol and platelet-fibrin emboli typically arise from atheromas in the carotid arteries, whereas calcium emboli often arise from cardiac valves.<xref ref-type="bibr" rid="article-19136.r22">[22]</xref> On fundoscopy, calcium emboli appear white, cholesterol emboli, also known as Hollenhorst plaques, appear orange, and platelet-fibrin emboli appear dull white.<xref ref-type="bibr" rid="article-19136.r23">[23]</xref>&#x000a0;Retinal emboli may comprise other materials, such as talc; malignancy; fat,&#x000a0;emboli resulting from&#x000a0;long bone fractures;&#x000a0;and infectious material commonly observed in patients with septicemia.</p>
        <table-wrap id="article-19136.table0" position="float" orientation="portrait">
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 250px;" rowspan="1" colspan="1">
<bold>Cholesterol Emboli (Hollenhorst Plaques)</bold>
</td>
                <td style="width: 174px;" rowspan="1" colspan="1">
<bold>Platelet-Fibrin Emboli</bold>
</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">
<bold>Calcific Emboli</bold>
</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Color</td>
                <td style="width: 250px;" rowspan="1" colspan="1">Yellowish orange</td>
                <td style="width: 174px;" rowspan="1" colspan="1">Dull gray-white</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">Chalky white</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Size</td>
                <td style="width: 250px;" rowspan="1" colspan="1">Small</td>
                <td style="width: 174px;" rowspan="1" colspan="1">It can be long, involving a segment of a retinal&#x000a0;artery&#x000a0;or arteriole</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">Large</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Number</td>
                <td style="width: 250px;" rowspan="1" colspan="1">Multiple in up to 70% of cases</td>
                <td style="width: 174px;" rowspan="1" colspan="1">May be multiple</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">Typically single, may lie over or very near the optic disc</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Appearance</td>
                <td style="width: 250px;" rowspan="1" colspan="1">Refractile, may be mobile</td>
                <td style="width: 174px;" rowspan="1" colspan="1">Smooth, may be mobile</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">May be irregular</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">&#x000a0;Shape</td>
                <td style="width: 250px;" rowspan="1" colspan="1">Globular (or rectangular)</td>
                <td style="width: 174px;" rowspan="1" colspan="1">Concave meniscus at each end</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">Round or oval&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Location</td>
                <td style="width: 250px;" rowspan="1" colspan="1">At the bifurcation of the retinal artery&#x000a0;or arteriole</td>
                <td style="width: 174px;" rowspan="1" colspan="1">A segment of a vessel</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">At the first or second bifurcation</td>
              </tr>
              <tr>
                <td style="width: 66px;" rowspan="1" colspan="1">Usual source</td>
                <td style="width: 250px;" rowspan="1" colspan="1">
<p>Commonly, internal or common carotid artery (sometimes from a brachiocephalic&#x000a0;artery or aorta)</p>
</td>
                <td style="width: 174px;" rowspan="1" colspan="1">The endothelial wall of an atherosclerotic vessel and heart (valves)</td>
                <td style="width: 147.301px;" rowspan="1" colspan="1">Calcified cardiac valves or an atheromatous plaque</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>In-situ thrombosis may also cause CRAO. Thrombi may&#x000a0;arise from various disorders, including atherosclerotic diseases, collagen-vascular disease, inflammatory states, and hypercoagulable states.<xref ref-type="bibr" rid="article-19136.r24">[24]</xref> Predisposing conditions of CRAO include but are not limited to polycythemia vera, sickle cell anemia, multiple myeloma, factor V Leiden, prothrombin III mutation, hyperhomocysteinemia, activated protein C resistance, Beh&#x000e7;et disease, pyoderma gangrenosum, and syphilis.<xref ref-type="bibr" rid="article-19136.r10">[10]</xref><xref ref-type="bibr" rid="article-19136.r25">[25]</xref>&#x000a0;Cosmetic facial injections or fillers can cause CRAO if the agent is inadvertently injected inside an artery communicating with the central retinal artery.<xref ref-type="bibr" rid="article-19136.r26">[26]</xref></p>
        <p>The causes of arteritic CRAO include giant cell arteritis, systemic lupus erythematosus,&#x000a0;polyarteritis nodosa, antiphospholipid syndrome,&#x000a0;granulomatosis with polyangiitis, and Takayasu arteritis.<xref ref-type="bibr" rid="article-19136.r27">[27]</xref>&#x000a0;Rapid differentiation between thromboembolic&#x000a0;and arteritic processes is essential as optimal therapy differs, and the rapid administration of steroids for vasculitic causes of CRAO is associated with improved outcomes. Typically, this is completed by checking for inflammatory markers, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), which are raised in giant cell arteritis.<xref ref-type="bibr" rid="article-19136.r28">[28]</xref></p>
        <p>Hayreh and Zimmerman classified CRAO into 4 groups as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nonarteritic CRAO (66%) is caused by a permanent occlusion of the central retinal artery&#x000a0;due to an embolus at the narrowest part of its course at its entry into the optic sheath.</p>
          </list-item>
          <list-item>
            <p>Nonarteritic CRAO with cilioretinal artery sparing (13%).</p>
          </list-item>
          <list-item>
            <p>Transient&#x000a0;nonarteritic CRAO (16%) is a&#x000a0;temporary blockage of the central retinal artery&#x000a0;lasting from minutes to hours. This&#x000a0;transient&#x000a0;occlusion can occur due to various factors, including&#x000a0;a migrating embolus, increased intraocular pressure, or a transient severe fall of perfusion pressure of the central retinal artery.</p>
          </list-item>
          <list-item>
            <p>Arteritic CRAO (5%) is caused by the occlusion of the common trunk of the central retinal artery and the posterior ciliary artery, typically due to giant cell arteritis.<xref ref-type="bibr" rid="article-19136.r2">[2]</xref><xref ref-type="bibr" rid="article-19136.r29">[29]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19136.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of CRAO is approximately 1 to 1.9 per 100,000 people in the United States, with less than 2% presenting with bilateral involvement.<xref ref-type="bibr" rid="article-19136.r3">[3]</xref><xref ref-type="bibr" rid="article-19136.r8">[8]</xref>&#x000a0;The age-standardized incidence of CRAO is&#x000a0;2.53 per 100,000 person-year in Japan,&#x000a0;2.7 per 100,000 person-year in Germany, and 1.8&#x000a0;per 100,000 person-year in Korea.<xref ref-type="bibr" rid="article-19136.r30">[30]</xref><xref ref-type="bibr" rid="article-19136.r31">[31]</xref>&#x000a0;The incidence increases with age, with around 10 per 100,000 person-year in&#x000a0;adults aged 80 or older.<xref ref-type="bibr" rid="article-19136.r32">[32]</xref>&#x000a0;The reported incidence&#x000a0;and mean age at presentation may vary according to geographical location, but it typically&#x000a0;occurs in individuals aged 60 to 70.<xref ref-type="bibr" rid="article-19136.r33">[33]</xref>&#x000a0;However, CRAO can also occur in the pediatric age group related to non-atherosclerotic causes, including trauma, embolism from calcified cardiac valves, and infection.<xref ref-type="bibr" rid="article-19136.r34">[34]</xref> Men have a slightly higher incidence compared to women.<xref ref-type="bibr" rid="article-19136.r35">[35]</xref> Patients diagnosed with CRAO have a life expectancy of 5.5 years compared to 15.4 years for age-matched patients with non-CRAO.<xref ref-type="bibr" rid="article-19136.r36">[36]</xref><xref ref-type="bibr" rid="article-19136.r37">[37]</xref> Risk factors for CRAO are similar to those of other thromboembolic diseases and include hypertension; smoking; hyperlipidemia; diabetes; high body mass index (BMI); dyslipidemia; atrial fibrillation; hypercoagulable states; cardiac disease, including rheumatic heart disease and other cardiac valve diseases; and male gender.<xref ref-type="bibr" rid="article-19136.r10">[10]</xref><xref ref-type="bibr" rid="article-19136.r25">[25]</xref>&#x000a0;Approximately&#x000a0;37% to 40%&#x000a0;of patients with CRAO have clinically significant ipsilateral carotid artery stenosis.<xref ref-type="bibr" rid="article-19136.r38">[38]</xref><xref ref-type="bibr" rid="article-19136.r39">[39]</xref><xref ref-type="bibr" rid="article-19136.r40">[40]</xref></p>
      </sec>
      <sec id="article-19136.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In the clinical setting where occlusion may be incomplete, the return of vision may be achieved after delays of 8 to 24 hours.&#x000a0;Up to&#x000a0;25% of the population receives significant macular collateral circulation from the cilioretinal artery.<xref ref-type="bibr" rid="article-19136.r41">[41]</xref> Patients with this anatomical variant typically have less severe presentations and better long-term prognoses.&#x000a0;</p>
        <p>Retinal ganglion cell infarction takes an indeterminate amount of time following total CRAO. However,&#x000a0;some experts speculate that&#x000a0;the process might be less than 15 minutes. In a study by Hayreh and colleagues,&#x000a0;the central retinal&#x000a0;artery was clamped in rhesus monkeys with hypertension and atherosclerosis aged 38.&#x000a0;The monkeys were evaluated using fundus photo, fluorescein angiography, visual evoked potential, and electroretinography.&#x000a0;This&#x000a0;study found that the retina did not suffer detectable damage in histopathology, electrophysiology, and morphometric analysis in CRAO of 97 minutes in this experimental model.&#x000a0;However,&#x000a0;after this critical time, irreversible damage increased as the time of CRAO increased.<xref ref-type="bibr" rid="article-19136.r42">[42]</xref>&#x000a0;This experimental model may not&#x000a0;be extrapolated directly for CRAO in humans.<xref ref-type="bibr" rid="article-19136.r43">[43]</xref><xref ref-type="bibr" rid="article-19136.r44">[44]</xref>&#x000a0;The function of the ischemic brain stops within seconds, and tissue necrosis can occur in the brain within 5 minutes of ceasing the supply of oxygen and glucose.<xref ref-type="bibr" rid="article-19136.r45">[45]</xref>&#x000a0;Retinal ganglion cells are also recognized as part of the brain tissue.<xref ref-type="bibr" rid="article-19136.r46">[46]</xref>&#x000a0;Thus, the exact time for infarction of the retina after CRAO may need further evaluation. However, incomplete or intermittent forms of CRAO exist that can have a satisfactory visual outcome after prompt diagnosis and therapy.</p>
        <p>The retina receives blood from&#x000a0;2 vascular systems. The central retinal&#x000a0;artery supplies the inner retina, and choriocapillaris supplies the retinal pigment epithelium and outer retina, typically starting from the outer plexiform layer.<xref ref-type="bibr" rid="article-19136.r47">[47]</xref>&#x000a0;Short posterior ciliary arteries supply choriocapillaris. The watershed zone of the&#x000a0;2 systems may vary in individuals due to differences in retinal thickness, light exposure, and specific retinal locations. When the central retinal&#x000a0;artery is occluded, the inner retina, specifically the nerve fiber and ganglion cell layer, becomes ischemic and loses transparency.<xref ref-type="bibr" rid="article-19136.r2">[2]</xref></p>
      </sec>
      <sec id="article-19136.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The central retinal&#x000a0;artery is the first intraorbital branch of the ophthalmic artery.<xref ref-type="bibr" rid="article-19136.r48">[48]</xref>&#x000a0;The artery enters the optic nerve&#x000a0;1 cm&#x000a0;posterior to the globe and supplies blood to the retina.<xref ref-type="bibr" rid="article-19136.r49">[49]</xref>&#x000a0;The&#x000a0;CRAO results in inner retinal ischemia, vision loss, and eventual necrosis. Acute CRAO results in retinal edema and pyknosis of the ganglion cell nuclei. As ischemia progresses, the retina becomes opacified and&#x000a0;takes on a yellow-white appearance.</p>
      </sec>
      <sec id="article-19136.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>CRAO typically presents with sudden, painless, monocular vision and visual field loss that occurs over seconds. Patients may report an&#x000a0;antecedent transient visual loss, also known as amaurosis fugax, and a history of atherosclerotic disease.<xref ref-type="bibr" rid="article-19136.r50">[50]</xref>&#x000a0;In patients with no light perception, ophthalmic artery occlusion, abnormalities in the optic nerve, and occluded short posterior ciliary arteries should be excluded.<xref ref-type="bibr" rid="article-19136.r51">[51]</xref></p>
        <p>Patients with CRAO often present with severe monocular vision loss and an afferent pupillary defect, also known as Marcus Gunn pupil.<xref ref-type="bibr" rid="article-19136.r52">[52]</xref>&#x000a0;The relative afferent pupillary defect may not be noticeable if the fellow eye has a damaged retina or optic nerve due to preexisting diseases, including glaucoma. The visual acuity can vary from loss of light perception to finger counting. According to Hayreh and Zimmerman, approximately 75% of patients with CRAO present with vision of finger counting or worse.<xref ref-type="bibr" rid="article-19136.r29">[29]</xref> Occasionally, some patients have visual acuity better than 20/40. The causes of good visual acuity in CRAO may include collateral circulation, sparing of fovea due to patent cilioretinal artery, peripheral retinal arterial occlusion, retrograde blood flow through the central retinal&#x000a0;artery, paracentral acute middle maculopathy, individual variability, and incomplete or partial CRAO.<xref ref-type="bibr" rid="article-19136.r53">[53]</xref><xref ref-type="bibr" rid="article-19136.r54">[54]</xref>&#x000a0;The evolution of CRAO may progress from mild retinal whitening with hyperreflectivity of the inner nuclear layer, which is only visible on optical coherence tomography (OCT) before the full-fledged fundus appearance is observed.<xref ref-type="bibr" rid="article-19136.r55">[55]</xref> Intraocular pressures, anterior chamber examinations, and extraocular eye movements are within normal limits.</p>
        <p>A thorough fundoscopic examination is crucial for accurate diagnosis of CRAO, and a dilated examination should be performed on any patient without contradictions to mydriatic medications who presents with symptoms&#x000a0;suggestive of CRAO. The patient may have a normal-looking fundus&#x000a0;on&#x000a0;a cursory examination. The typical white retina and cherry red spot may take&#x000a0;hours to be<bold>&#x000a0;</bold>present on ophthalmoscopy<bold>.</bold> However, inner retinal hyperreflectivity may be observed on OCT in the early stages of CRAO.<xref ref-type="bibr" rid="article-19136.r56">[56]</xref>&#x000a0;Severe sudden onset vision loss and relative afferent pupillary defect in the eye are other indicators. The retina appears diffusely pale on fundoscopy with a cherry red&#x000a0;macular&#x000a0;spot.<xref ref-type="bibr" rid="article-19136.r9">[9]</xref>&#x000a0;The whitening of the retina results from ischemia of the nerve fiber layer around the fovea, which becomes opaque and swollen. A cherry red spot&#x000a0;at the macula results from the preserved choroidal circulation (perfused and red vascular choroid)&#x000a0;visible beneath the thin fovea with a surrounding white retina that blocks the view of the vascular choroid. The retinal whitening may be more appreciable when comparing the fundus picture of the involved eye with the&#x000a0;fellow normal eye. Some cases of CRAO may not show a cherry red spot at the macula.<xref ref-type="bibr" rid="article-19136.r57">[57]</xref>&#x000a0;</p>
        <p>Narrowing, boxcarring, also known as cattle-tracking, or slow segmental blood flow&#x000a0;in the arterioles or venules may also be observed (see&#x000a0;<bold>Image.</bold>&#x000a0;Central Retinal Arterial Occlusion). The&#x000a0;blood flow through the retinal artery is slow and can be visualized by the movement of the&#x000a0;segments of blood&#x000a0;during the slit-lamp biomicroscopic examination using a 90D lens. The slow blood flow through the arterioles is also prominently observed&#x000a0;during fluorescein angiography.&#x000a0;In this procedure, the dye filling of the arteriole progresses slowly. This observation is better appreciated by comparing early images of the involved eye taken in rapid succession or using video angiography.<xref ref-type="bibr" rid="article-19136.r58">[58]</xref>&#x000a0;Retinal&#x000a0;arteriolar&#x000a0;caliber may be irregularly narrowed. Cilioretinal arteries&#x000a0;arising from short posterior ciliary arteries are present in around 15% to 25% of patients, and these typically supply the fovea. Thus, in CRAO with the patent cilioretinal artery (cilioretinal artery sparing), the central vision may be maintained. However, the visual field is severely reduced (see&#x000a0;<bold>Image</bold>. Central Retinal Artery Occlusion with Cilioretinal Artery Sparing). Typically, no retinal hemorrhage of retinal venous dilation and tortuosity occurs, as noted in central retinal venous occlusion. Multiple cotton wool spots characterize transient nonarteritic CRAO and may appear&#x000a0;similar to Purtscher retinopathy.<xref ref-type="bibr" rid="article-19136.r59">[59]</xref></p>
        <p>In up to 40% of cases,&#x000a0;arteriolar emboli may be visualized.<xref ref-type="bibr" rid="article-19136.r60">[60]</xref> Other conditions, such as commotio retinae, Tay-Sachs disease, and Niemann-Pick disease, may present with a cherry red spot on fundoscopic examinations but can be easily differentiated based on clinical presentation.<xref ref-type="bibr" rid="article-19136.r61">[61]</xref><xref ref-type="bibr" rid="article-19136.r62">[62]</xref> Arteritic CRAO&#x000a0;almost always has a pale edematous disc suggestive of arteritic anterior ischemic optic neuropathy with characteristics&#x000a0;of CRAO.<xref ref-type="bibr" rid="article-19136.r63">[63]</xref><xref ref-type="bibr" rid="article-19136.r64">[64]</xref><xref ref-type="bibr" rid="article-19136.r65">[65]</xref>&#x000a0;Arteritic&#x000a0;CRAO should be suspected in&#x000a0;older patients with a history of jaw claudication, polymyalgia rheumatica, and scalp tenderness. Ipsilateral carotid artery disease may cause a contralateral motor or sensory deficit.<xref ref-type="bibr" rid="article-19136.r66">[66]</xref>&#x000a0;The carotid pulse should be checked.</p>
      </sec>
      <sec id="article-19136.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>CRAO is analogous to a cerebral vascular accident involving the retina. As such, the workup for CRAO closely parallels the workup for stroke or transient ischemic attacks.<xref ref-type="bibr" rid="article-19136.r12">[12]</xref>&#x000a0;The ophthalmic workup includes a photo of the color fundus and an OCT of the macula. The color fundus photograph typically reveals retinal whitening in the involved eye compared to the&#x000a0;contralateral&#x000a0;eye. Cherry red spots at the macula may or may not be visible. The OCT of the macula shows inner retinal hyperreflectivity in the acute phase (see <bold>Image</bold>. Optical Coherence Tomography of Macula in Central Retinal Artery Occlusion). Some cases of CRAO may have paracentral acute middle maculopathy characterized by hyperreflectivity of the inner nuclear layer.<xref ref-type="bibr" rid="article-19136.r67">[67]</xref>&#x000a0;Over time, the thinning of the inner retina becomes apparent. A fundus fluorescein angiogram (FFA) is not required for the diagnosis. However,&#x000a0;the FFA shows a slow progression of the dye in the arterioles (see <bold>Image</bold>. Fundus Fluorescein Angiogram in Central Retinal Artery Occlusion). The choroid fills normally in nonarteritic CRAO. An absent or late filling of the retinal arterioles may occur. The choroidal phase may show hypoperfusion in arteritic CRAO or ophthalmic artery occlusion. In some cases of CRAO, the FFA may be normal.<xref ref-type="bibr" rid="article-19136.r58">[58]</xref><xref ref-type="bibr" rid="article-19136.r68">[68]</xref>&#x000a0;</p>
        <p>Initial blood work should include point-of-care glucose, a complete blood count with differential, and coagulation assays, including prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (PTT). An ESR and CRP should be obtained to rule out giant cell arteritis. If inflammatory markers are elevated, and the patient's history and physical examination findings&#x000a0;are consistent with giant cell arteritis, high-dose intravenous (IV) steroids should be initiated immediately.<xref ref-type="bibr" rid="article-19136.r69">[69]</xref>&#x000a0;Temporal biopsy should be planned in such cases within 2 weeks of the initiation of steroid therapy.<xref ref-type="bibr" rid="article-19136.r70">[70]</xref><xref ref-type="bibr" rid="article-19136.r71">[71]</xref></p>
        <p>If symptom onset occurs within a window of less than 4.5 hours, a computed tomography (CT) head without contrast should be obtained to rule out intracranial hemorrhage and assess the patient's eligibility for thrombolytic therapy.<xref ref-type="bibr" rid="article-19136.r8">[8]</xref>&#x000a0;Other tests should be considered based on individual risk factors and medical history.<bold>&#x000a0;</bold>These tests include&#x000a0;hemoglobin A1c (glycated hemoglobin), lipid profile, Rh factor (rheumatoid factor), antinuclear antibody, fluorescent treponemal antibody absorption test, hypercoagulability labs, carotid artery imaging, electrocardiogram, echocardiogram, and outpatient Holter monitoring.<xref ref-type="bibr" rid="article-19136.r72">[72]</xref>&#x000a0;Carotid artery imaging is a crucial part of systemic evaluation as the most common source of embolus. The imaging&#x000a0;modalities include carotid duplex ultrasound, CT, magnetic resonance, and digital subtraction angiography. If carotid imaging is normal, cardiac evaluation should&#x000a0;include modalities&#x000a0;such as&#x000a0;echocardiography.&#x000a0;Patients with CRAO&#x000a0;require interprofessional collaboration&#x000a0;among ophthalmologists, cardiologists, primary care&#x000a0;clinicians or internists, and neurologists.</p>
      </sec>
      <sec id="article-19136.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The visual prognosis of CRAO remains poor despite treatment, and ongoing research aims to identify&#x000a0;evidence-based, effective, and safe therapy. No consensus is available regarding the optimal treatment for CRAO, although early IV thrombolytic administration shows promise.<xref ref-type="bibr" rid="article-19136.r73">[73]</xref>&#x000a0;Time is&#x000a0;crucial in management, and&#x000a0;treatment should be started before the diagnosis is confirmed. Proposed therapies are aimed at restoring retinal perfusion or oxygenation. Basic strategies include vasodilation, causing ocular hypotony so that the thrombus or embolus dislodges, increasing oxygen tension, surgical removal of the clot, or thrombolysis.&#x000a0;Lifestyle modification and control of systemic factors are essential for secondary prevention.</p>
        <p>
<bold>Various therapies have been tried with variable success:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Immediate ocular massage:&#x000a0;Ocular massage&#x000a0;may induce oscillations of intraocular pressure and dislodge the offending thrombus. The patient is seated on a slit-lamp comfortably. Pressure is applied on the globe with a 3-mirror Goldmann lens for 10 seconds until&#x000a0;retinal arterial pulsations are visible. If the pulsations are not visible, cessation of arterial flow should be obtained, followed by the release of pressure for 5 seconds. In the absence of a slit-lamp or Goldmann lens, digital ocular massage may be tried. However, ocular massage is not a standard treatment for CRAO.&#x000a0;Research on&#x000a0;the effectiveness is limited and inconclusive, although described since the 1880s.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drugs&#x000a0;to reduce intraocular pressure:&#x000a0;IV acetazolamide 500 mg, mannitol (1.5 to 2 g/kg over 30 to 60 min), and topical timolol (0.5%,&#x000a0;1 drop twice daily) may be started to reduce intraocular pressure, which can increase the perfusion pressure (mean arterial pressure or intraocular pressure).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Anterior chamber paracentesis:&#x000a0;Paracentesis is&#x000a0;often recommended in conjunction&#x000a0;with or after failed digital ocular massage. A 26- or 27-gauge needle is inserted into the anterior chamber anteriorly to the limbus, and around 0.1 to 0.2 mL of&#x000a0;aqueous liquid is drained.&#x000a0;This action is expected to cause sudden ocular hypotony and possible dilation of retinal arteries.&#x000a0;However, anterior chamber paracentesis caused a maximum 20% rise in retinal arterial flow in animal studies.&#x000a0;Complications of this procedure include hyphema and endophthalmitis. A study on 74&#x000a0;patients with CRAO found no added benefit of anterior chamber paracentesis compared to conservative treatment. The authors recommended against use in CRAO, considering the risks of ocular injury and infection.<xref ref-type="bibr" rid="article-19136.r74">[74]</xref><xref ref-type="bibr" rid="article-19136.r75">[75]</xref><xref ref-type="bibr" rid="article-19136.r76">[76]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Carbogen:&#x000a0;A mixture of 95% oxygen and 5% carbon dioxide inhalation is thought to cause vasodilation and increased oxygen supply to the retina.&#x000a0;Carbogen is given 10 minutes per 1 hour during waking and 10 minutes per 4 hours during sleep. The therapy is continued for 2 to 3 days.&#x000a0;A study involving 89 cases of patients with acute CRAO failed to show the benefit of combined anterior chamber paracentesis with carbogen inhalation compared to&#x000a0;no&#x000a0;interventions.<xref ref-type="bibr" rid="article-19136.r77">[77]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperventilation into a paper bag: Respiratory acidosis and vasodilation are induced by either&#x000a0;hyperventilation into a paper bag&#x000a0;or by inhaling 10% carbon dioxide.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pentoxifylline:&#x000a0;The recommended dosage for this hemorheological agent is three&#x000a0;600 mg tablets daily. The hemorheological agent works by increasing erythrocyte flexibility, reducing blood viscosity, and improving perfusion. The medication&#x000a0;has been tested in patients with CRAO and shown&#x000a0;to increase retinal flow, although studies evaluating this drug have multiple limitations.<xref ref-type="bibr" rid="article-19136.r78">[78]</xref><xref ref-type="bibr" rid="article-19136.r79">[79]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sublingual&#x000a0;isosorbide dinitrate:&#x000a0;10 mg of isosorbide&#x000a0;dinitrate<bold>&#x000a0;</bold>causes vasodilation and has been utilized in managing CRAO, although comprehensive studies on its efficacy are currently insufficient.<xref ref-type="bibr" rid="article-19136.r80">[80]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Supplemental oxygen</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>IV&#x000a0;methylprednisolone:&#x000a0;The mainstay of therapy to manage arteritic CRAO caused by giant cell arteritis is&#x000a0;1 g/d for 1 to 3 days. This dose reduces inflammatory causes and retinal edema.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>IV&#x000a0;thrombolysis (fibrinolysis):<bold>&#x000a0;</bold>The most commonly used&#x000a0;therapy&#x000a0;is the&#x000a0;IV infusion of alteplase, also known as tissue plasminogen activator, 0.9 mg/kg. The initial 10% dose is delivered rapidly in 1 minute, and the rest is delivered&#x000a0;through slow infusion for 59 minutes.&#x000a0;Around&#x000a0;5.8% of patients with CRAO in the United States receive tissue plasminogen activator. A patient-level meta-analysis found that thrombolysis was more beneficial&#x000a0;compared to the natural history group when&#x000a0;administered&#x000a0;within 4.5 hours of onset.&#x000a0;Larger randomized controlled trials are necessary to further evaluate the role of&#x000a0;IV fibrinolysis in treating patients with CRAO. The American Heart Association recommends considering&#x000a0;IV thrombolysis in nonarteritic CRAO within 4.5 hours without any systemic contraindications of&#x000a0;IV thrombolysis.<xref ref-type="bibr" rid="article-19136.r81">[81]</xref><xref ref-type="bibr" rid="article-19136.r82">[82]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Intra-arterial thrombolysis:<bold>&#x000a0;</bold>In the EAGLE study, a&#x000a0;catheter was super selectively inserted into the ophthalmic artery, and a maximum of 50 mg of recombinant tissue plasminogen activator was injected.&#x000a0;This study was prematurely stopped due to safety concerns as intra-arterial thrombolysis had similar efficacy but higher adverse events compared to conservative standard treatment.&#x000a0;Adverse events of this procedure include dislodgment of atheromatous plaque, arterial dissection, and spasms. The American Heart Association recommends considering intra-arterial thrombolysis in centers with this facility for&#x000a0;patients who are not candidates for&#x000a0;IV thrombolysis and who have presented within 6 hours.<xref ref-type="bibr" rid="article-19136.r8">[8]</xref><xref ref-type="bibr" rid="article-19136.r39">[39]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperbaric oxygen therapy: This therapy aims to increase blood oxygen tension. Typically, 2 to 2.5 atm is administered for 90 minutes within 8 hours of symptom onset.<xref ref-type="bibr" rid="article-19136.r1">[1]</xref><xref ref-type="bibr" rid="article-19136.r83">[83]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Neodymium:yttrium-aluminum-garnet laser embolectomy: The&#x000a0;neodymium:yttrium-aluminum-garnet laser (1064 nm) is used to lyse the embolus applying power up to 2 mJ.&#x000a0;This procedure is performed using a fundus contact lens&#x000a0;such as Goldmann 3-mirror or&#x000a0;Volk Quadraspheric lens.&#x000a0;A meta-analysis noted that although&#x000a0;the procedure was associated with visual recovery in most cases, vitreous hemorrhage was frequent.&#x000a0;Higher pulse energy may be associated with more vitrectomies and cause subretinal or vitreous hemorrhage.<xref ref-type="bibr" rid="article-19136.r84">[84]</xref><xref ref-type="bibr" rid="article-19136.r85">[85]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pars plana vitrectomy:&#x000a0;The procedure with a longitudinal incision over the artery or arteriole and thrombus removal has been reported in a few cases.<xref ref-type="bibr" rid="article-19136.r79">[79]</xref><xref ref-type="bibr" rid="article-19136.r86">[86]</xref><xref ref-type="bibr" rid="article-19136.r87">[87]</xref><xref ref-type="bibr" rid="article-19136.r88">[88]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19136.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of CRAO includes several conditions.</p>
        <list list-type="bullet">
          <list-item>
            <p>Ophthalmic artery occlusion: Ophthalmic artery occlusion is characterized by incomplete or complete occlusion of the ophthalmic artery, resulting in severe ischemia or infarction of the globe and surrounding structures. Visual acuity&#x000a0;typically means no perception of light, and the cherry red spot at the macula may not be visible due to choroidal ischemia.</p>
          </list-item>
          <list-item>
            <p>Paracentral acute middle maculopathy: Paracentral acute middle maculopathy is characterized by hyperreflectivity of the inner nuclear layer on the OCT macula.&#x000a0;Some cases with aracentral acute middle maculopathy may progress to CRAO, and this may denote a spectrum of ischemic disorders.</p>
          </list-item>
          <list-item>
            <p>Purtscher retinopathy:&#x000a0;Purtscher flecken may simulate cotton wool spots observed in transient nonarteritic CRAO.</p>
          </list-item>
          <list-item>
            <p>Hypertensive retinopathy<bold>:&#x000a0;</bold>The retinopathy is bilateral&#x000a0;with arteriovenous changes, papilledema, cotton wool spots around the optic disc, and subretinal fluid around the disc extending up to the nasal side of the fovea. The blood pressure is raised severely.</p>
          </list-item>
          <list-item>
            <p>Differential diagnoses of a cherry red spot at the macula include lysosomal storage disorders, commotion retinae, retinitis around the optic disc, and adverse relations of drugs.<xref ref-type="bibr" rid="article-19136.r9">[9]</xref><xref ref-type="bibr" rid="article-19136.r59">[59]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19136.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The visual prognosis of CRAO remains poor despite the recent advances in the medical field. Less than 10% to 20% of patients with CRAO regain functional vision.<xref ref-type="bibr" rid="article-19136.r82">[82]</xref><xref ref-type="bibr" rid="article-19136.r89">[89]</xref>&#x000a0;A large study&#x000a0;involving&#x000a0;130&#x000a0;patients with CRAO showed that visual improvement was most notable in cases of transient nonarteritic CRAO, with approximately 82% of affected eyes showing improvement from baseline vision of finger counting or worse.&#x000a0;Around 67% of eyes with nonarteritic CRAO with patent cilioretinal artery had experienced visual gain compared to 22% with nonarteritic CRAO.&#x000a0;The vision typically improved within the first 7 days.<xref ref-type="bibr" rid="article-19136.r29">[29]</xref></p>
        <p>CRAO has been included in the definition of acute ischemic stroke, which encompasses an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction, as outlined by the American Heart Association.<xref ref-type="bibr" rid="article-19136.r8">[8]</xref>&#x000a0;Similar to acute ischemic stroke, CRAO is associated with an increased risk of recurrent vascular events.<xref ref-type="bibr" rid="article-19136.r90">[90]</xref><xref ref-type="bibr" rid="article-19136.r91">[91]</xref>&#x000a0;Retinal arterial occlusion&#x000a0;may result in higher mortality rates compared to the general population.<xref ref-type="bibr" rid="article-19136.r92">[92]</xref></p>
      </sec>
      <sec id="article-19136.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Patients with CRAO eventually develop inner retinal thinning and optic atrophy. Around 20% of cases develop neovascularization of the iris, typically after 30 to 60 days, although&#x000a0;this may occur within 1 week. Such cases need panretinal photocoagulation with or without intravitreal anti-vascular endothelial growth factor (anti-VEGF agents) injection.<xref ref-type="bibr" rid="article-19136.r93">[93]</xref>&#x000a0;The chances of the other eye involvement are high with arteritic CRAO in giant cells, and arteritis and&#x000a0;IV high-dose steroids may prevent the involvement of the other eye.<xref ref-type="bibr" rid="article-19136.r94">[94]</xref>&#x000a0;As mentioned, the risk of arterial thromboembolic events and mortality may be high after CRAO, and patients should be informed.</p>
      </sec>
      <sec id="article-19136.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be aware of the signs and symptoms of CRAO, such as sudden, painless vision loss.&#x000a0;The urgency of seeking immediate medical attention in the event of sudden vision loss should be emphasized, along with the recommendation to regularly check their vision by closing alternate eyes to detect any sudden visual decline. Time is critical in preserving vision, and delays may result in irreversible damage. CRAO is a medical emergency, and although no therapy&#x000a0;is effective in such cases, early diagnosis and prompt initiation of available treatment may improve visual outcomes.</p>
        <p>Common risk factors for CRAO, such as hypertension, diabetes, cardiovascular disease, and hyperlipidemia, should be discussed. Patients should be encouraged to manage and control these risk factors through lifestyle modifications, including avoidance of smoking, and medications.&#x000a0;Patients should be advised about the necessity of undergoing a thorough examination&#x000a0;by healthcare professionals, including eye specialists and possibly vascular specialists, to determine the underlying cause of CRAO and guide appropriate treatment decisions.&#x000a0;The uncertain prognosis for visual recovery in CRAO should be discussed. Although some individuals may experience partial or complete recovery,&#x000a0;most of the patients (around 80%) may have permanent vision loss.&#x000a0;</p>
        <p>The outcome depends on factors such as the extent of ischemia and the effectiveness of interventions. Follow-up with eye care professionals and other relevant specialists should be emphasized. Regular monitoring is essential to assess the patient's visual function, manage risk factors, and address potential complications.&#x000a0;The emotional impact of sudden vision loss should be acknowledged, and information should be provided about available support services, including counseling or support groups, to help patients cope with the psychological aspects of the condition. To reduce the risk of vascular events, the patients should be educated on lifestyle modifications, such as maintaining a healthy diet, exercising regularly, managing blood pressure and cholesterol levels, and&#x000a0;refraining from smoking.<xref ref-type="bibr" rid="article-19136.r95">[95]</xref></p>
      </sec>
      <sec id="article-19136.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Healthcare professionals should promptly refer patients exhibiting signs of CRAO to an ophthalmologist. CRAO is the sudden blockage of the central retinal&#x000a0;artery, resulting in retinal hypoperfusion, rapidly progressive cellular damage, and vision loss. Retina survival depends on the degree of&#x000a0;collateralization and the duration of retinal ischemia. Prompt diagnosis and early treatment to dislodge or lyse the offending embolus or thrombus is crucial to avoid irreversible retinal damage and blindness.</p>
        <p>The prognosis for these patients depends on the timing of diagnosis and initiation of treatment. Individuals treated promptly often regain their sight, but delay can cause some degree of vision loss and, in some cases, permanent blindness.&#x000a0;The team treating a patient with CRAO may include&#x000a0;ophthalmologists, cardiologists, primary care physicians or internists, neurologists, nurses, and pharmacists. Ophthalmologists help confirm the diagnosis and follow up on the ocular condition. The cardiologists perform a detailed search for the source of the embolus and ensure optimal cardiovascular health. The internists or the primary care&#x000a0;clinicians&#x000a0;refer to the ophthalmologists urgently without delay and in following up on the patient's systemic condition. Neurologists help exclude cerebrovascular accidents and follow up on such cases. The nursing staff monitors the patient. Pharmacists&#x000a0;help patients with&#x000a0;medication management. Effective communication and collaboration among team members facilitate a swift response, improving patient care.&#x000a0;This holistic approach ensures that the patient receives prompt management, leading to a potentially better outcome that includes preserving vision.<xref ref-type="bibr" rid="article-19136.r96">[96]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-19136.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19136&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19136">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/central-retinal-artery-occlusion-eye-stroke/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19136">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19136/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19136">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19136.s16">
        <fig id="article-19136.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Central Retinal Arterial Occlusion. The retina appears whitened, and the blood column is segmented (boxcarring) around the fovea. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crao" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19136.s17">
        <fig id="article-19136.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Central Retinal Artery Occlusion With Cilioretinal Artery Sparing. In cases of central retinal artery occlusion with a patent cilioretinal artery (cilioretinal artery sparing), the central vision may be maintained, but the visual field is severely reduced. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crao__clra" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19136.s18">
        <fig id="article-19136.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Optical Coherence Tomography of Macula in Central Retinal Artery Occlusion. The image shows inner retinal hyperreflectivity in the acute phase. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CRAO__OCT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19136.s19">
        <fig id="article-19136.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Fundus Fluorescein Angiogram in Central Retinal Artery Occlusion. The image shows a slow progression of dye in the retinal arteries. The photos were captured at 35 seconds and 37 seconds, respectively, after the intravenous injection of sodium fluorescein dye. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ffa__crao" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19136.s20">
        <title>References</title>
        <ref id="article-19136.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cugati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Treatment options for central retinal artery occlusion.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-77</page-range>
            <pub-id pub-id-type="pmid">23070637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1684</fpage>
            <page-range>1684-1694</page-range>
            <pub-id pub-id-type="pmid">30451166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varma</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Cugati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>A review of central retinal artery occlusion: clinical presentation and management.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>688</fpage>
            <page-range>688-97</page-range>
            <pub-id pub-id-type="pmid">23470793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avery</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Magal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kherani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitha</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Risk of Stroke in Patients With Ocular Arterial Occlusive Disorders: A Retrospective Canadian Study.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2019</year>
            <month>Feb</month>
            <day>05</day>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>e010509</fpage>
            <pub-id pub-id-type="pmid">30712440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mir</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Arham</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Alqahtani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alkhouli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hinkle</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Acute Vascular Ischemic Events in Patients With Central Retinal Artery Occlusion in the United States: A Nationwide Study 2003-2014.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>200</volume>
            <fpage>179</fpage>
            <page-range>179-186</page-range>
            <pub-id pub-id-type="pmid">30689989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Relationship between retinal vascular occlusions and incident cerebrovascular diseases: A systematic review and meta-analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>26</issue>
            <fpage>e4075</fpage>
            <pub-id pub-id-type="pmid">27368050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dattilo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biousse</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Update on the Management of Central Retinal Artery Occlusion.</article-title>
            <source>Neurol Clin</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-100</page-range>
            <pub-id pub-id-type="pmid">27886897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mac Grory</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biousse</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Furie</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Gerhard-Herman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sobrin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tjoumakaris</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Weyand</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Yaghi</surname>
                <given-names>S</given-names>
              </name>
              <collab>American Heart Association Stroke Council; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; and Council on Peripheral Vascular Disease</collab>
            </person-group>
            <article-title>Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.</article-title>
            <source>Stroke</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>e282</fpage>
            <page-range>e282-e294</page-range>
            <pub-id pub-id-type="pmid">33677974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <chapter-title>Cherry Red Spot</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">30969663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mazumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarma</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Central retinal arterial occlusion in a patient with pyoderma gangrenosum.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>7</issue>
            <fpage>1019</fpage>
            <page-range>1019-1021</page-range>
            <pub-id pub-id-type="pmid">29941761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kou</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Progress in central retinal artery occlusion: a narrative review.</article-title>
            <source>J Int Med Res</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>51</volume>
            <issue>9</issue>
            <fpage>3000605231198388</fpage>
            <pub-id pub-id-type="pmid">37712755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madike</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cugati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A review of the management of central retinal artery occlusion.</article-title>
            <source>Taiwan J Ophthalmol</source>
            <year>2022</year>
            <season>Jul-Sep</season>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>273</fpage>
            <page-range>273-281</page-range>
            <pub-id pub-id-type="pmid">36248088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Babikian</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wijman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Koleini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matjucha</surname>
                <given-names>IC</given-names>
              </name>
            </person-group>
            <article-title>Retinal ischemia and embolism. Etiologies and outcomes based on a prospective study.</article-title>
            <source>Cerebrovasc Dis</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-13</page-range>
            <pub-id pub-id-type="pmid">11490104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahuja</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eliott</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Puklin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of retinal arterial occlusive disease in African American and Caucasian patients.</article-title>
            <source>Stroke</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>1506</fpage>
            <page-range>1506-9</page-range>
            <pub-id pub-id-type="pmid">10436091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flaxel</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Adelman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Fawzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Vemulakonda</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern&#x000ae;.</article-title>
            <source>Ophthalmology</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>P259</fpage>
            <page-range>P259-P287</page-range>
            <pub-id pub-id-type="pmid">31757501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kaufman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Mahabadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Munakomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <chapter-title>Hollenhorst Plaque</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">29261979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saw</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors of retinal arteriolar emboli: the Singapore Malay Eye Study.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>146</volume>
            <issue>4</issue>
            <fpage>620</fpage>
            <page-range>620-4</page-range>
            <pub-id pub-id-type="pmid">18639861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Donnell</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The clinical features and associations of retinal emboli.</article-title>
            <source>Aust N Z J Ophthalmol</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-7</page-range>
            <pub-id pub-id-type="pmid">1599661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cugati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rochtchina</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Ten-year incidence of retinal emboli in an older population.</article-title>
            <source>Stroke</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>908</fpage>
            <page-range>908-10</page-range>
            <pub-id pub-id-type="pmid">16439697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Leeder</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of asymptomatic retinal emboli in an Australian urban community.</article-title>
            <source>Stroke</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-6</page-range>
            <pub-id pub-id-type="pmid">8996490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Earnshaw</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stratton</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sykes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scanlon</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>A potential pathway for managing diabetic patients with arterial emboli detected by retinal screening.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-7</page-range>
            <pub-id pub-id-type="pmid">21616692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramakrishna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Malouf</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Younge</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Calcific retinal embolism as an indicator of severe unrecognised cardiovascular disease.</article-title>
            <source>Heart</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>91</volume>
            <issue>9</issue>
            <fpage>1154</fpage>
            <page-range>1154-7</page-range>
            <pub-id pub-id-type="pmid">16103545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>The Characteristics of Retinal Emboli and its Association With Vascular Reperfusion in Retinal Artery Occlusion.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>57</volume>
            <issue>11</issue>
            <fpage>4589</fpage>
            <page-range>4589-98</page-range>
            <pub-id pub-id-type="pmid">27598864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ashorobi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ameer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Thrombosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">30860701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fujino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Oct</month>
            <day>27</day>
            <volume>11</volume>
            <issue>21</issue>
            <pub-id pub-id-type="pmid">36362567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asensio-S&#x000e1;nchez</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion following facial injection of hyaluronic acid.</article-title>
            <source>Arch Soc Esp Oftalmol (Engl Ed)</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>98</volume>
            <issue>7</issue>
            <fpage>410</fpage>
            <page-range>410-412</page-range>
            <pub-id pub-id-type="pmid">37247664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Luthra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shrinkhal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Takayasu's arteritis: a unique ophthalmic presentation with CRAO and BRVO.</article-title>
            <source>BMJ Case Rep</source>
            <year>2019</year>
            <month>Aug</month>
            <day>15</day>
            <volume>12</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31420422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Podhajsky</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Giant cell arteritis: validity and reliability of various diagnostic criteria.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>285</fpage>
            <page-range>285-96</page-range>
            <pub-id pub-id-type="pmid">9063237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion: visual outcome.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>140</volume>
            <issue>3</issue>
            <fpage>376</fpage>
            <page-range>376-91</page-range>
            <pub-id pub-id-type="pmid">16138997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kido</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Miyake</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hiragi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsujikawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011-2015).</article-title>
            <source>BMJ Open</source>
            <year>2020</year>
            <month>Sep</month>
            <day>24</day>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>e041104</fpage>
            <pub-id pub-id-type="pmid">32973068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nickels</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saalmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Finger</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Incidence of retinal artery occlusion in Germany.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>e656</fpage>
            <page-range>e656-e657</page-range>
            <pub-id pub-id-type="pmid">32026572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011.</article-title>
            <source>Ophthalmology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>121</volume>
            <issue>10</issue>
            <fpage>1933</fpage>
            <page-range>1933-8</page-range>
            <pub-id pub-id-type="pmid">24913283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ivanisevi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karelovi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The incidence of central retinal artery occlusion in the district of Split, Croatia.</article-title>
            <source>Ophthalmologica</source>
            <year>2001</year>
            <season>May-Jun</season>
            <volume>215</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-6</page-range>
            <pub-id pub-id-type="pmid">11340401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fazi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fortunato</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trapani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion in a young child affected by COVID-19: a first case report.</article-title>
            <source>BMC Pediatr</source>
            <year>2023</year>
            <month>Sep</month>
            <day>13</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>462</fpage>
            <pub-id pub-id-type="pmid">37704960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leavitt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Gullerud</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>The incidence of central retinal artery occlusion in Olmsted County, Minnesota.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>152</volume>
            <issue>5</issue>
            <fpage>820</fpage>
            <page-range>820-3.e2</page-range>
            <pub-id pub-id-type="pmid">21794842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gala</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Karimi</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Turbin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Prestigiacomo</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Current endovascular treatment options for central retinal arterial occlusion: a review.</article-title>
            <source>Neurosurg Focus</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>E7</fpage>
            <pub-id pub-id-type="pmid">24380484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grzybowski</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mimier</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the Association between the Risk of Central Retinal Artery Occlusion and the Concentration of Environmental Air Pollutants.</article-title>
            <source>J Clin Med</source>
            <year>2019</year>
            <month>Feb</month>
            <day>07</day>
            <volume>8</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30736427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Kappelle</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Eliasziw</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Babikian</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis.</article-title>
            <source>Stroke</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>1963</fpage>
            <page-range>1963-7</page-range>
            <pub-id pub-id-type="pmid">12154246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schumacher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jurklies</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wanke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schmoor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maier-Lenz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Solymosi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brueckmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Neubauer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feltgen</surname>
                <given-names>N</given-names>
              </name>
              <collab>EAGLE-Study Group</collab>
            </person-group>
            <article-title>Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>117</volume>
            <issue>7</issue>
            <fpage>1367</fpage>
            <page-range>1367-75.e1</page-range>
            <pub-id pub-id-type="pmid">20609991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lavin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Patrylo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hollar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Espaillat</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Kirshner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>200</volume>
            <fpage>271</fpage>
            <page-range>271-272</page-range>
            <pub-id pub-id-type="pmid">30827486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Acute retinal arterial occlusive disorders.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>359</fpage>
            <page-range>359-94</page-range>
            <pub-id pub-id-type="pmid">21620994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion. Retinal survival time.</article-title>
            <source>Exp Eye Res</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>723</fpage>
            <page-range>723-36</page-range>
            <pub-id pub-id-type="pmid">15106952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobalem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schutz</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chronopoulos</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion - rethinking retinal survival time.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2018</year>
            <month>Apr</month>
            <day>18</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <pub-id pub-id-type="pmid">29669523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chronopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schutz</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion-A new, provisional treatment approach.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2019</year>
            <season>Jul-Aug</season>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>443</fpage>
            <page-range>443-451</page-range>
            <pub-id pub-id-type="pmid">30707925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r45">
          <label>45</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>DeSai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hays Shapshak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Cerebral Ischemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">32809345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ruzafa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aires</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Pereiro</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ambr&#x000f3;sio</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Vecino</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santiago</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.</article-title>
            <source>Int J Mol Sci</source>
            <year>2020</year>
            <month>Mar</month>
            <day>25</day>
            <volume>21</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">32218163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LEH</given-names>
              </name>
            </person-group>
            <article-title>Retinal Vasculature in Development and Diseases.</article-title>
            <source>Annu Rev Vis Sci</source>
            <year>2018</year>
            <month>Sep</month>
            <day>15</day>
            <volume>4</volume>
            <fpage>101</fpage>
            <page-range>101-122</page-range>
            <pub-id pub-id-type="pmid">30222533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r48">
          <label>48</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Motlagh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Head and Neck, Eye Arteries</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">30725748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merriam</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Casper</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>The entry point of the central retinal artery into the outer meningeal sheath of the optic nerve.</article-title>
            <source>Clin Anat</source>
            <year>2021</year>
            <month>May</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>605</fpage>
            <page-range>605-608</page-range>
            <pub-id pub-id-type="pmid">32530060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r50">
          <label>50</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tadi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Najem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Margolin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Amaurosis Fugax</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">29261995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Magargal</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery obstruction and visual acuity.</article-title>
            <source>Ophthalmology</source>
            <year>1982</year>
            <month>Jan</month>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-9</page-range>
            <pub-id pub-id-type="pmid">7070767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r52">
          <label>52</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Marcus Gunn Pupil</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32491607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carranza-Casas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aceves-Velazquez</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cano-Hidalgo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Graue-Wiechers</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Partial Central Retinal Artery Occlusion: An Underrecognized Entity.</article-title>
            <source>Int Med Case Rep J</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>637</fpage>
            <page-range>637-642</page-range>
            <pub-id pub-id-type="pmid">33273866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gong</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Visual acuity assessment of central retinal artery occlusion patients with or without paracentral acute middle maculopathy via OCT-A.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2023</year>
            <month>Oct</month>
            <day>13</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>412</fpage>
            <pub-id pub-id-type="pmid">37833625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakhoum</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Dolz-Marco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>BCS</given-names>
              </name>
              <name>
                <surname>Baumal</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sarraf</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Paracentral Acute Middle Maculopathy and the Ischemic Cascade Associated With Retinal Vascular Occlusion.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>195</volume>
            <fpage>143</fpage>
            <page-range>143-153</page-range>
            <pub-id pub-id-type="pmid">30081014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenzel</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kromer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Poli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Steinhorst</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Casagrande</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Spitzer</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography-based determination of ischaemia onset - the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>e247</fpage>
            <page-range>e247-e252</page-range>
            <pub-id pub-id-type="pmid">32767551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion without cherry-red spots.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2023</year>
            <month>Oct</month>
            <day>25</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>434</fpage>
            <pub-id pub-id-type="pmid">37880636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r58">
          <label>58</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r59">
          <label>59</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <chapter-title>Purtscher Retinopathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">31194324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sivalingam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Reber</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>339</fpage>
            <page-range>339-42</page-range>
            <pub-id pub-id-type="pmid">1706177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Extensive commotio retinae involving peripheral retina.</article-title>
            <source>Natl Med J India</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>242</fpage>
            <pub-id pub-id-type="pmid">29162764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gogia</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Choroidal coloboma in a case of tay-sachs disease.</article-title>
            <source>Case Rep Ophthalmol Med</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>760746</fpage>
            <pub-id pub-id-type="pmid">25295204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kruszewski</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tamhankar</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic Manifestations of Giant Cell Arteritis.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2023</year>
            <month>Apr</month>
            <day>01</day>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>13</fpage>
            <page-range>13-23</page-range>
            <pub-id pub-id-type="pmid">36963824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1974</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>964</fpage>
            <page-range>964-80</page-range>
            <pub-id pub-id-type="pmid">4376416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Podhajsky</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Ocular manifestations of giant cell arteritis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>125</volume>
            <issue>4</issue>
            <fpage>509</fpage>
            <page-range>509-20</page-range>
            <pub-id pub-id-type="pmid">9559737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r66">
          <label>66</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Qaja</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tadi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Theetha Kariyanna</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Symptomatic Carotid Artery Stenosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">28723054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Association of Paracentral Acute Middle Maculopathy with Visual Prognosis in Retinal Artery Occlusion: A Retrospective Cohort Study.</article-title>
            <source>J Ophthalmol</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>9404973</fpage>
            <pub-id pub-id-type="pmid">35637681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Fundus changes in central retinal artery occlusion.</article-title>
            <source>Retina</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>276</fpage>
            <page-range>276-89</page-range>
            <pub-id pub-id-type="pmid">17460582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>IC</given-names>
              </name>
            </person-group>
            <article-title>Giant cell arteritis presenting as central retinal artery occlusion.</article-title>
            <source>QJM</source>
            <year>2022</year>
            <month>Jan</month>
            <day>21</day>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-33</page-range>
            <pub-id pub-id-type="pmid">34264347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r70">
          <label>70</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ameer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vaqar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khazaeni</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Giant Cell Arteritis (Temporal Arteritis)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">29083688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achkar</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lie</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hunder</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>O'Fallon</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?</article-title>
            <source>Ann Intern Med</source>
            <year>1994</year>
            <month>Jun</month>
            <day>15</day>
            <volume>120</volume>
            <issue>12</issue>
            <fpage>987</fpage>
            <page-range>987-92</page-range>
            <pub-id pub-id-type="pmid">8185147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Callizo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feltgen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pantenburg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neubauer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Jurklies</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wachter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schmoor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Junker</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pielen</surname>
                <given-names>A</given-names>
              </name>
              <collab>European Assessment Group for&#x000a0;Lysis&#x000a0;in&#x000a0;the Eye</collab>
            </person-group>
            <article-title>Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination.</article-title>
            <source>Ophthalmology</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>122</volume>
            <issue>9</issue>
            <fpage>1881</fpage>
            <page-range>1881-8</page-range>
            <pub-id pub-id-type="pmid">26231133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grigg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Markus</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.</article-title>
            <source>Stroke</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>2229</fpage>
            <page-range>2229-34</page-range>
            <pub-id pub-id-type="pmid">21757667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beatty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Au Eong</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management.</article-title>
            <source>J Accid Emerg Med</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>324</fpage>
            <page-range>324-9</page-range>
            <pub-id pub-id-type="pmid">11005400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ffytche</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>A rationalization of treatment of central retinal artery occlusion.</article-title>
            <source>Trans Ophthalmol Soc U K (1962)</source>
            <year>1974</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>468</fpage>
            <page-range>468-79</page-range>
            <pub-id pub-id-type="pmid">4619853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fie&#x000df;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cal</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Kehrein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Halstenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Frisch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Steinhorst</surname>
                <given-names>UH</given-names>
              </name>
            </person-group>
            <article-title>Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy?</article-title>
            <source>BMC Ophthalmol</source>
            <year>2014</year>
            <month>Mar</month>
            <day>10</day>
            <volume>14</volume>
            <fpage>28</fpage>
            <pub-id pub-id-type="pmid">24612658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atebara</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Cater</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion.</article-title>
            <source>Ophthalmology</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>102</volume>
            <issue>12</issue>
            <fpage>2029</fpage>
            <page-range>2029-34; discussion 2034-5</page-range>
            <pub-id pub-id-type="pmid">9098313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Incandela</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cesarone</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Belcaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Steigerwalt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Sanctis</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Nicolaides</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geroulakos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramaswami</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial.</article-title>
            <source>Angiology</source>
            <year>2002</year>
            <season>Jan-Feb</season>
            <volume>53 Suppl 1</volume>
            <fpage>S31</fpage>
            <page-range>S31-4</page-range>
            <pub-id pub-id-type="pmid">11865833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraser</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Interventions for acute non-arteritic central retinal artery occlusion.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2009</year>
            <month>Jan</month>
            <day>21</day>
            <volume>2009</volume>
            <issue>1</issue>
            <fpage>CD001989</fpage>
            <pub-id pub-id-type="pmid">19160204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rumelt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dorenboim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rehany</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Aggressive systematic treatment for central retinal artery occlusion.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-8</page-range>
            <pub-id pub-id-type="pmid">10612510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nedelmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Graef</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weinand</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wassill</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kaps</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lorenz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tanislav</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion.</article-title>
            <source>Stroke</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>2322</fpage>
            <page-range>2322-4</page-range>
            <pub-id pub-id-type="pmid">26111890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schrag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Youn</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirshner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.</article-title>
            <source>JAMA Neurol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>72</volume>
            <issue>10</issue>
            <fpage>1148</fpage>
            <page-range>1148-54</page-range>
            <pub-id pub-id-type="pmid">26258861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Hagan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murphy-Lavoie</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy and the eye.</article-title>
            <source>Undersea Hyperb Med</source>
            <year>2008</year>
            <season>Sep-Oct</season>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>333</fpage>
            <page-range>333-87</page-range>
            <pub-id pub-id-type="pmid">19024664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehboob</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mukhtar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of YAG Laser Embolysis in Retinal Artery Occlusion.</article-title>
            <source>Pak J Med Sci</source>
            <year>2021</year>
            <season>Jan-Feb</season>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-75</page-range>
            <pub-id pub-id-type="pmid">33437253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Man</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hecht</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Talitman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hilely</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Midlij</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burgansky-Eliash</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Achiron</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of retinal artery occlusion using transluminal Nd:YAG laser: a systematic review and meta-analysis.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>255</volume>
            <issue>10</issue>
            <fpage>1869</fpage>
            <page-range>1869-1877</page-range>
            <pub-id pub-id-type="pmid">28823062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Youn</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Patrylo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirshner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current treatment of central retinal artery occlusion: a national survey.</article-title>
            <source>J Neurol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>265</volume>
            <issue>2</issue>
            <fpage>330</fpage>
            <page-range>330-335</page-range>
            <pub-id pub-id-type="pmid">29236169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Arum&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martinez-Castillo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Boixadera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fonollosa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corcostegui</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Surgical embolus removal in retinal artery occlusion.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>90</volume>
            <issue>10</issue>
            <fpage>1252</fpage>
            <page-range>1252-5</page-range>
            <pub-id pub-id-type="pmid">16854826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Topping</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Vitreous surgery for central retinal artery occlusion.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>118</volume>
            <issue>11</issue>
            <fpage>1586</fpage>
            <page-range>1586-7</page-range>
            <pub-id pub-id-type="pmid">11074821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Ocular vascular occlusive disorders: natural history of visual outcome.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>41</volume>
            <fpage>1</fpage>
            <page-range>1-25</page-range>
            <pub-id pub-id-type="pmid">24769221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chodnicki</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Klaas</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Stroke Risk Before and After Central Retinal Artery Occlusion in a US Cohort.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>236</fpage>
            <page-range>236-241</page-range>
            <pub-id pub-id-type="pmid">30711121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaikh</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Elsamna</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Zarbin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bhagat</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Assessing the risk of stroke development following retinal artery occlusion.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>105002</fpage>
            <pub-id pub-id-type="pmid">32807420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hwang</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Rim</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kyoung</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Incidence of Retinal Artery Occlusion and Related Mortality in Korea, 2005 to 2018.</article-title>
            <source>JAMA Netw Open</source>
            <year>2023</year>
            <month>Mar</month>
            <day>01</day>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>e233068</fpage>
            <pub-id pub-id-type="pmid">36897587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction.</article-title>
            <source>Ophthalmology</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-5</page-range>
            <pub-id pub-id-type="pmid">2465523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Giant cell arteritis: Its ophthalmic manifestations.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-235</page-range>
            <pub-id pub-id-type="pmid">33463564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rippe</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease.</article-title>
            <source>Am J Lifestyle Med</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-212</page-range>
            <pub-id pub-id-type="pmid">30800027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19136.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lentz</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Central Retinal Artery Occlusion: A Literature Review and the Rationale for Hyperbaric Oxygen Therapy.</article-title>
            <source>Mo Med</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-7</page-range>
            <pub-id pub-id-type="pmid">27039492</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
